Withus Pharmaceutical. Co., LTD
330350 | KO
Overview
Corporate Details
- ISIN(s):
- KR7330350000
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 동산로12길 9, 서초구
- Website:
- https://withuspharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 942.7 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 918.9 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 22.9 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.0 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.9 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 404.2 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 124.2 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.2 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.6 KB | ||
| 2025-02-12 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.9 KB | ||
| 2024-12-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-20 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-11-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 74.4 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 840.0 KB | ||
| 2024-09-19 00:00 |
Regulatory Filings
생산중단
|
Korean | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Withus Pharmaceutical. Co., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Withus Pharmaceutical. Co., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Withus Pharmaceutical. Co., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops oral ACLY inhibitors to lower high LDL-C and cardiovascular risk.
United States of America
ESPR
United States of America
ESPR
Develops novel small molecule drugs to treat castration-resistant prostate cancer.
United States of America
EPIX
United States of America
EPIX
Clinical-stage biopharma developing ARTEMIS® T-cell therapies for cancer & autoimmune disease.
United States of America
ESLA
United States of America
ESLA
Develops and commercializes innovative treatments for rare pediatric diseases.
United States of America
ETON
United States of America
ETON
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea
206650
South Korea
206650
Developing targeted, extended-release therapies for GI and musculoskeletal diseases.
United States of America
EPRX
United States of America
EPRX
A SPAC acquiring European biomanufacturers to create a large-scale CDMO for advanced therapies.
France
KINGS
France
KINGS
Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.
France
EAPI
France
EAPI
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
France
ALERS
France
ALERS
Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.
Sweden
EURI B
Sweden
EURI B